logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Homozygous Familial Hypercholesterolemia Hofh

    Medications for Homozygous Familial Hypercholesterolemia Hofh

    FiltersReset Filters
    16 results

    • atorvastatin calcium

      (Atorvastatin calcium)
      NIVAGEN PHARMACEUTICALS, INC.
      Usage: Atorvastatin calcium is indicated to reduce the risk of myocardial infarction, stroke, and angina in at-risk adults. It also lowers LDL cholesterol in adults with hyperlipidemia, heterozygous or homozygous familial hypercholesterolemia, and treats primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet.

    • crestor

      (Rosuvastatin)
      AstraZeneca Pharmaceuticals LP
      Usage: CRESTOR is indicated for reducing the risk of major cardiovascular events in adults at increased risk, as an adjunct to diet for lowering LDL cholesterol in various hyperlipidemias, and for treating primary dysbetalipoproteinemia and hypertriglyceridemia in adults. It is also used in pediatric patients with familial hypercholesterolemia.

    • ezetimibe and simvastatin

      (Ezetimibe and Simvastatin)
      AvKARE
      Usage: Ezetimibe and simvastatin tablets are indicated as adjunct therapy to diet for reducing cholesterol and triglyceride levels in patients with primary or mixed hyperlipidemia, including homozygous familial hypercholesterolemia. They are part of a comprehensive approach to reduce the risk of atherosclerotic vascular disease.

    • juxtapid

      (lomitapide mesylate)
      Amryt Pharmaceuticals DAC
      Usage: JUXTAPID is indicated as an adjunct therapy to a low-fat diet and other lipid-lowering treatments for reducing LDL-C, total cholesterol, apo B, and non-HDL-C in patients with homozygous familial hypercholesterolemia (HoFH). Its safety and effectiveness are not established for other hypercholesterolemia types.

    • repatha

      (Evolocumab)
      Amgen USA Inc.
      Usage: REPATHA is indicated for reducing the risk of major adverse cardiovascular events in adults with established cardiovascular disease, and as an adjunct to diet and other therapies to lower LDL cholesterol in adults and pediatric patients (ages 10+) with primary hyperlipidemia, heterozygous, or homozygous familial hypercholesterolemia.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Shandong New Time Pharmaceutical Co., Ltd.
      Usage: Rosuvastatin is indicated for reducing cardiovascular risk in adults without coronary heart disease, lowering LDL-C in various hyperlipidemia types, treating familial hypercholesterolemia in children and adults, and addressing primary dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet and other therapies.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      UMEDICA LABORATORIES PRIVATE LIMITED
      Usage: Rosuvastatin is indicated to reduce cardiovascular event risk in adults without coronary heart disease, lower LDL cholesterol in various forms of hyperlipidemia (primary, familial), and treat dysbetalipoproteinemia and hypertriglyceridemia as an adjunct to diet in both adults and pediatric patients aged 7 years and older.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      TORRENT PHARMACEUTICALS LIMITED
      Usage: Rosuvastatin is indicated to reduce the risk of major cardiovascular events in adults at increased risk, and as an adjunct to diet for lowering LDL cholesterol in various conditions, including primary hyperlipidemia, heterozygous familial hypercholesterolemia, and homozygous familial hypercholesterolemia in both adults and children.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Cadila Pharmaceuticals Limited
      Usage: Rosuvastatin tablets are indicated for reducing cardiovascular disease risk in adults, managing hyperlipidemia, and treating familial hypercholesterolemia in patients aged 7 and older. They also help reduce LDL-C and slow atherosclerosis progression, and are used alongside diet and other therapies for cholesterol control.

    • rosuvastatin calcium

      (Rosuvastatin Calcium)
      Ascend Laboratories, LLC
      Usage: Rosuvastatin tablets are indicated to reduce cardiovascular risks in adults at increased risk, lower LDL-C in those with primary hyperlipidemia, and treat heterozygous or homozygous familial hypercholesterolemia in pediatric and adult patients. It also aids in managing primary dysbetalipoproteinemia and hypertriglyceridemia.